CDC Data Shows HIV Prevention Pill Underused; Minorities in Minnesota Potentially at Risk

Why it matters locally: The CDC's report on underutilization of PrEP, particularly among minority populations, is directly relevant to Minnesota. With a diverse population of 5.7 million, Minnesota faces similar challenges in healthcare access and equity. If PrEP is underutilized within the state, it could lead to higher HIV infection rates, especially within vulnerable communities. The lack of preventative measures can strain the state's public health resources, increase healthcare costs, and impact the well-being of individuals and families.

---

Denver, CO - A new analysis released by the Centers for Disease Control and Prevention (CDC) indicates that pre-exposure prophylaxis (PrEP), a medication used to prevent HIV infection, is not being utilized by a significant portion of the at-risk population in the United States. The findings were presented at the 2018 Conference on Retroviruses and Opportunistic Infections. The CDC analysis highlights that disparities exist in PrEP access and uptake, with people of color being disproportionately affected. Data suggests that a considerable number of individuals who could benefit from PrEP are not receiving or utilizing the medication. Further details regarding the specific methodology of the CDC analysis, the size and demographics of the study population, and specific data points on PrEP usage rates were not immediately available. Further information is expected to be released by the CDC in the near future.